The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...

Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

The Small Cell Lung Cancer market report also offers comprehensive insights into the Small Cell Lung Cancer market size, ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

In the Phase III DeLLphi-304 trial, patients with small cell lung cancer administered Imdelltra achieved a statistically ...

The approval of Imfinzi was granted based on results from the pivotal ADRIATIC Phase III trial which demonstrated statistically significant and clinically meaningful results for its dual primary ...

A new spit test for prostate cancer which can be done at home may be better than current testing methods, a study suggests. Experts have developed a simple saliva test which analyses genetic ...

While Cullen’s prognosis is good “because we caught it so early,” her mother points out that “it can also cause problems like cancer in the future ... popcorn lung is irreversible.” ...

discusses the significant benefits of durvalumab (Imfinzi) as consolidation therapy following standard chemoradiotherapy for patients with limited-stage small cell lung cancer (SCLC), based on ...

Dame Esther Rantzen has issued a candid update on her health, following her diagnosis with stage four lung cancer two years ago. The broadcasting legend, who was at one point given just weeks to live, ...